Clinical Coordinating Center for the Severe Asthma Research Program (SARP) (U10)

Post Date

May 26th 2010

Application Due Date

October 15th 2010

Funding Opportunity Number

RFA-HL-11-030

CFDA Number(s)

93.838

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $31500000

• Award Range:

  $None - $None

Grant Description

Purpose. The National Heart, Lung, and Blood Institute invites applications to participate as the Clinical Coordinating Center (CCC) in the NHLBI Severe Asthma Research Program (SARP). Accumulating evidence suggests that severe asthma is complex and phenotypically heterogeneous across individuals and time. Not knowing the underlying mechanisms and stability of these sub-phenotypes impedes the development of effective treatments and management strategies. This phase of SARP will develop a new paradigm for understanding severe asthma and its sub-phenotypes, in children and adults, by defining disease at the molecular and cellular level longitudinally. The new SARP investigators will use mechanistic and evoked phenotype approaches to characterize developmental molecular, cellular and physiologic phenotypes in children and adults with mild to severe asthma and to further elucidate the evolving pathobiology and pathogenesis of severe asthma and its sub-phenotypes. SARP investigators will work together to identify the important research questions that require a shared longitudinal protocol which will be conducted across all participating centers and which will include common information on all SARP participants. In addition, SARP investigators will identify research questions separate from those proposed for the shared longitudinal protocol which may be investigated using the shared protocol or in participants from one or more centers. The overall aim is to enable prediction of phenotype stability / fluctuation and pharmacologic response, and to identify novel, disease-modifying targets for treatment. This longitudinal mechanistic research approach will provide integrated understanding of the fixed and variable molecular, cellular, and pathophysiologic underpinnings of severe asthma sub-phenotypes. Cross-sectional studies or therapeutic trials are not the intent of this FOA. This program will require multidisciplinary research collaboration and partnerships between asthma clinician-scientists and scientists with expertise in areas such as immunology, pulmonary physiology, molecular genetics, molecular phenotyping, imaging, and bioinformatics. SARP will consist of up to six Clinical Centers, a Clinical Coordinating Center, and a Steering Committee. This FOA solicits applications for the Clinical Coordinating Center and runs parallel with a separate FOA that solicits applications for Clinical Centers (see RFA-HL-11-018)

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-11-030.html